New Leaf Venture Partners, L.L.C. Crispr Therapeutics Ag Transaction History

New Leaf Venture Partners, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $12.5 Million - $18.2 Million	-444,708 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $6.43 Million - $11.1 Million	-150,934 Reduced 25.34%	444,708 $26.1 Million
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $2.07 Million - $5.11 Million	87,912 Added 17.31%	595,642 $27.2 Million
Q4 2017 Feb 14, 2018	SELL	$16.95 - $23.48 $339,000 - $469,600	-20,000 Reduced 3.79%	507,730 $11.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	527,730	527,730 $8.45 Million

550

56.3M

2.91M

2.47M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.14B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.